GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » Risk Assessment

Pulike Biological Engineering (SHSE:603566) Risk Assessment


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Pulike Biological Engineering is: Low Risk: Strong fundamentals, worth long-term holding.


Competitive Comparison of Pulike Biological Engineering's Risk Assessment

For the Biotechnology subindustry, Pulike Biological Engineering's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's Risk Assessment Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's Risk Assessment falls into.


;
;

Pulike Biological Engineering  (SHSE:603566) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Pulike Biological Engineering Risk Assessment Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Hu Wei Director
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering Headlines

No Headlines